2224P Identifying prognostic factors in patients with radioiodine-refractory differentiated thyroid carcinoma (RR-DTC) treated with tyrosine kinase inhibitors (TKI): Data from REGETNE registry

M.V. San Roman Gil, J. Hernando, A.R. Granados,A. Carmona, G. Marquina Ospina, M.R. Bella, B. Castelo, S.E. Campos Ramirez,J. Molina Cerrillo, I. Ruz-Caracuel, P. Valderrabano, P. Luengo Pierrard, M. Roca Herrera,A. Garcia Alvarez,J. Pozas Perez, C. Gonzalez Merino,T. Alonso Gordoa,J. Capdevila Castillon

Annals of Oncology(2023)

引用 0|浏览1
暂无评分
关键词
thyroid carcinoma,tyrosine kinase inhibitors,radioiodine-refractory,rr-dtc
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要